Most commonly seen in post-menopausal women, survivors of
breast cancer, and women who have undergone a hysterectomy, atrophic vaginitis causes the
vaginal walls to lose elasticity and moisture due to decreased estrogen
production, resulting in painful sex. In the US alone, "as many
as 50% of 64 million post-menopausal women suffer from changes to their
gynecologic health*, and over 2.8M breast cancer survivors**" Cynosure
reports. To counteract this often painful diagnosis, DEKA,
an Italian company, created MonaLisa Touch.
Cynosure states that MonaLisa Touch "delivers
fractional CO2laser energy to
the vaginal wall tissue," healing the vaginal walls and building up the
lost tissues and elasticity.
In December, 2014, the FDA approved the MonaLisa Touch laser,
marking the beginnings of the procedure's introduction to the United States
medical field. Because the procedure is new, and originated in Europe, much
information is still unavailable to US patients. With the FDA approval, though,
this procedure begin to make it's way into the mainstream medical field.
SmileMonaLisa writes:
"MonaLisa Touch is a medical laser that delivers controlled energy to the
vaginal tissue so cells make more collagen, thus, revitalizing the vaginal
mucosa and increasing moisture."
The laser is small enough so no anesthesia is needed. The
treatment costs $1500 for three treatments, although price will vary depending
on health insurance and on which country the procedure takes place in. The
procedures are all spaced six weeks apart. Each procedure occurs in a
physicians office and is done in under five minutes. No anesthesia is required,
and no pain is felt.
While MonaLisa Touch still has a journey to making it to
mainstream medical fields all over the globe, the procedure opens up the doors
for communication about vaginal atrophy, something that many women are afraid
to discuss.
More information about MonaLisa Touch can be found at SmileMonaLisa,
Cynosure, and MonaLisa Touch.
* US Census, 2010 ** National Institutes of Health 2011
No comments:
Post a Comment